Asimily provides a risk management platform that inventories and classifies every device across a healthcare organization, both connected and standalone, using an extensive knowledge base of IoT and security protocols. The platform continuously monitors devices, detects anomalous behavior, and alerts operators to remediate identified issues. Recent product additions include a built-in policy management module for network-wide searches and a Distributed Sniffer for incident response and forensics. The company says its platform now secures more than 20 million medical IoT devices and analyzes more than 1,000 terabytes of data daily. Led by CEO Shankar Somasundaram, Asimily plans to use new funding to accelerate development of platform tools and to expand further within the healthcare industry. Asimily offers an IoMT risk management platform that inventories and classifies connected and standalone medical and IoT devices, identifies and prioritizes vulnerabilities, and provides actionable intelligence and monitoring across the device lifecycle. The company has the largest knowledge base of IoMT and security protocols and delivers out-of-the-box hardening guides and integrations with firewalls, NAC providers, and configuration management systems. In 2021 Asimily launched a module to assess standalone-device risk and added multiple integrations, demonstrating ongoing product innovation. The company reports accelerated revenue and client growth and describes itself as a strong, organically growing, cash-flow-driven business. Asimily has strengthened its leadership team with hires such as Priyanka Upendra and received industry recognition including Gartner "Cool Vendor" and the Stratus Award. The announced funding is intended to seize global market opportunities and increase brand awareness as health systems digitize and expand device footprints.

Total raised

$10M

Funding rounds

2

Latest round

Equity

Latest activity

Nov 2021